CIK 0001372514
- Non-accelerated filer
- Smaller reporting company
KIORA PHARMACEUTICALS INC
Sign in to watch- Tickers
- KPRX KPHMW
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980443284
- Phone
- +1 858-224-9600
- Business address
- 169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
- Former names
- EYEGATE PHARMACEUTICALS INC
Securities
- KPRX Common Stock Nasdaq
- KPHMW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 73 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-08-06 | Romano Sarah Chief Financial Officer | Shares withheld for taxes | −1,649 | $0.21 | $346 | 260,464 |
| 2019-08-06 | MANZO MICHAEL P. VP of Engineering | Shares withheld for taxes | −1,649 | $0.21 | $346 | 173,147 |
| 2019-08-06 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −1,641 | $0.21 | $345 | 172,783 |
| 2019-08-06 | Wirostko Barbara Chief Medical Officer | Shares withheld for taxes | −1,641 | $0.21 | $345 | 403,893 |
| 2019-07-15 | Romano Sarah Chief Financial Officer | Sale | −6,584 | $0.23 | $2K | 262,113 |
| 2019-07-15 | MANZO MICHAEL P. VP of Engineering | Sale | −6,584 | $0.23 | $2K | 174,796 |
| 2019-07-15 | Wirostko Barbara Chief Medical Officer | Sale | −6,488 | $0.23 | $2K | 405,534 |
| 2019-07-15 | FROM STEPHEN President and CEO | Sale | −42,452 | $0.23 | $10K | 1,032,465 |
| 2019-07-15 | Mann Brenda VP of Research & Development | Sale | −6,350 | $0.23 | $1K | 174,424 |
| 2019-07-12 | Romano Sarah Chief Financial Officer | Sale | −6,583 | $0.24 | $2K | 268,697 |
| 2019-07-12 | MANZO MICHAEL P. VP of Engineering | Sale | −6,583 | $0.24 | $2K | 181,380 |
| 2019-07-12 | Wirostko Barbara Chief Medical Officer | Sale | −6,488 | $0.24 | $2K | 412,022 |
| 2019-07-12 | FROM STEPHEN President and CEO | Sale | −42,452 | $0.24 | $10K | 1,074,917 |
| 2019-07-12 | Mann Brenda VP of Research & Development | Sale | −6,350 | $0.24 | $1K | 180,774 |
| 2019-07-11 | Romano Sarah Chief Financial Officer | Sale | −6,583 | $0.24 | $2K | 275,280 |
| 2019-07-11 | MANZO MICHAEL P. VP of Engineering | Sale | −6,583 | $0.24 | $2K | 187,963 |
| 2019-07-11 | Wirostko Barbara Chief Medical Officer | Sale | −6,487 | $0.24 | $2K | 418,510 |
| 2019-07-11 | FROM STEPHEN President and CEO | Sale | −42,451 | $0.24 | $10K | 1,117,369 |
| 2019-07-11 | Mann Brenda VP of Research & Development | Sale | −6,349 | $0.24 | $2K | 187,124 |
| 2019-03-29 | ARMISTICE CAPITAL, LLC Director | Purchase | +298,189 | $0.31 | $92K | 17,812,500 |
Page 14 of 24 · 468 trades